z-logo
Premium
Protective effects of irigenin against 1‐methyl‐4‐phenylpyridinium ‐induced neurotoxicity through regulating the Keap1/Nrf2 pathway
Author(s) -
Guo Fen,
Wang Xiaoxue,
Liu Xinxin
Publication year - 2021
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.6926
Subject(s) - neurotoxicity , chemistry , superoxide dismutase , oxidative stress , malondialdehyde , apoptosis , viability assay , nitric oxide , mtt assay , catalase , keap1 , pharmacology , biochemistry , microbiology and biotechnology , biology , toxicity , organic chemistry , transcription factor , gene
The rhizome of Belamcanda chinensis possesses antiinflammatory and antioxidant activities. However, the effect of irigenin, isolated from the rhizome of B. chinensis , on 1‐methyl‐4‐phenylpyridinium (MPP + )‐induced neurotoxicity is unknown. MTT assay showed that MPP + exposure dose dependently inhibited the viability of mouse microglia BV‐2 cells, whereas irigenin suppressed MPP + ‐induced viability reduction. The production of nitric oxide, prostaglandin E2, tumor necrosis factor‐α and interleukin‐6 were increased by MPP + treatment, which were abolished by irigenin treatment. Irigenin‐attenuated MPP + ‐induced increase of malondialdehyde content and activities of superoxide dismutase, catalase and glutathione peroxidase in BV‐2 cells. Irigenin treatment also repressed apoptosis, caspase‐3/7 activity and Cytochrome C expression in MPP + ‐challenged BV‐2 cells. Interestingly, irigenin activated the Keap1/Nrf2 pathway in MPP + ‐induced BV‐2 cells. Nrf2 knockdown attenuated the effects of irigenin on MPP + ‐induced viability reduction, inflammation, oxidative stress and apoptosis in BV‐2 cells. In conclusion, irigenin alleviated MPP + ‐induced neurotoxicity in BV‐2 cells through regulating the Keap1/Nrf2 pathway.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom